Cargando…
Engineering a Reliable and Convenient SARS-CoV-2 Replicon System for Analysis of Viral RNA Synthesis and Screening of Antiviral Inhibitors
The etiologic agent of COVID-19 is highly contagious and has caused a severe global pandemic. Until now, there has been no simple and reliable system available in a lower-biosafety-grade laboratory for SARS-CoV-2 virologic research and inhibitor screening. In this study, we reported a replicon syste...
Autores principales: | Luo, Yuewen, Yu, Fei, Zhou, Mo, Liu, Yang, Xia, Baijin, Zhang, Xiantao, Liu, Jun, Zhang, Junsong, Du, Yingying, Li, Rong, Wu, Liyang, Zhang, Xu, Pan, Ting, Guo, Deyin, Peng, Tao, Zhang, Hui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7845634/ https://www.ncbi.nlm.nih.gov/pubmed/33468688 http://dx.doi.org/10.1128/mBio.02754-20 |
Ejemplares similares
-
A Convenient and Biosafe Replicon with Accessory Genes of SARS-CoV-2 and Its Potential Application in Antiviral Drug Discovery
por: Jin, Yun-Yun, et al.
Publicado: (2021) -
SARS-CoV-2 replicon for high-throughput antiviral screening
por: Zhang, Qiu-Yan, et al.
Publicado: (2021) -
Replicon RNA Viral Vectors as Vaccines
por: Lundstrom, Kenneth
Publicado: (2016) -
Viral replicons as valuable tools for drug discovery
por: Hannemann, Holger
Publicado: (2020) -
USP10 regulates B cell response to SARS-CoV-2 or HIV-1 nanoparticle vaccines through deubiquitinating AID
por: Luo, Yuewen, et al.
Publicado: (2022)